Open in app
Sign inGet started
New chapter in my career

New chapter in my career

Apologies for the radio silence over the past 18 months. My work life took an interesting turn and I’ve been swamped ever since setting up…
Go to the profile of Robert Thong
Robert Thong
Tracing 23andMe’s Journey

Tracing 23andMe’s Journey

Lessons for Consumer Genomics Companies
Go to the profile of Lakshmi Santhosh Maithel
Lakshmi Santhosh Maithel
Announcing My New Book for Startups

Announcing My New Book for Startups

At long last, I have now started serious work on my new book for startups: The Bioscience Startup Journey. Two chapters are already…
Go to the profile of Robert Thong
Robert Thong
Bioscience and Healthcare Megatrends that Startups Cannot Ignore

Bioscience and Healthcare Megatrends that Startups Cannot Ignore

Does your startup concept ride a megatrend? When evaluating a bioscience startup, my first filter is often whether that aspiring business…
Go to the profile of Robert Thong
Robert Thong
Two Common Business Model Misconceptions

Two Common Business Model Misconceptions

This blog post highlights two common misconceptions that bioscience startups often have with respect to their new venture’s business…
Go to the profile of Robert Thong
Robert Thong
Business Models for a Young Biotech

Business Models for a Young Biotech

What’s my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly…
Go to the profile of Robert Thong
Robert Thong
3 Drug Development Principles for Smart SMEs

3 Drug Development Principles for Smart SMEs

I was inspired to post this article after someone said to me, “The drug development skills learnt in big pharma translate naturally to the…
Go to the profile of Robert Thong
Robert Thong
Latest
To Be or Not To Be a Virtual Biotech

To Be or Not To Be a Virtual Biotech

Many new biotechs start off as virtual companies. But at each stage of development, you always end up asking whether you should stay…
Go to the profile of Robert Thong
Robert Thong
Is Big Always Best?

Is Big Always Best?

Many research-stage biotechs and other small to medium-sized enterprises (SMEs) prioritize partnerships with Big Partners or in Big…
Go to the profile of Robert Thong
Robert Thong
Lessons from Leicester City’s success for Bioscience SMEs

Lessons from Leicester City’s success for Bioscience SMEs

As the 2015–16 English Premier League football season ends, I reflect on the lessons that smaller/medium sized enterprises (SMEs) can…
Go to the profile of Robert Thong
Robert Thong
About SciTechStrategyLatest StoriesArchiveAbout MediumTermsPrivacyTeams